{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-027770","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2025-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.164720+00:00","generated_at":"2026-05-24T05:48:11.351415+00:00","sec_items":["1.01","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"confidence":"high","headline":"Entero Therapeutics rescinds 2024 ImmunogenX merger, retains $695K AP; names new CFO","bullets":["Rescission Agreement with ImmunogenX LLC signed March 24, 2025; unwinds the March 2024 merger.","Closing conditions include shareholder approval by June 30, 2025, lender consent, and resignation of director Jack Syage.","Company retains ~$695,000 of ImmunogenX accounts payable; ImmunogenX remains responsible for ~$9.28M secured debt.","Anna Skowron appointed CFO effective March 3, 2025; brings 14+ years of accounting and financial reporting experience.","CEO states rescission strengthens balance sheet and refocuses value creation strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-027770","json":"https://secwatch.observer/filing/0001104659-25-027770.json","markdown":"https://secwatch.observer/filing/0001104659-25-027770.md","text":"https://secwatch.observer/filing/0001104659-25-027770.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925027770/0001104659-25-027770-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925027770/tm2510211d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T05:48:11.351415+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}